Editorial: Vibratory therapy: impacts on endocrine disorders
Clinical Scorecard: The Effects of Vibratory Therapy on Endocrine Disorders
At a Glance
| Category | Detail |
|---|
| Condition | Endocrine disorders (e.g., osteoporosis, obesity, diabetes) |
| Key Mechanisms | Mechanical vibration stimulates mechanoreceptors, promoting hormone release and enhancing bone and metabolic health. |
| Target Population | Individuals with osteoporosis, obesity, diabetes, and related endocrine disorders. |
| Care Setting | Clinical settings, including multidisciplinary body weight reduction programs. |
Key Highlights
- Vibratory therapy (VT) may improve bone mineral density and reduce fracture risk.
- SVT shows potential as a non-pharmacological intervention for endocrine disorders.
- VT combined with active muscle contractions enhances biological effects.
- Research indicates VT can increase resting energy expenditure in obese adolescents.
- VT may regulate bone metabolism and support osteoporosis management.
Guideline-Based Recommendations
Diagnosis
- Consider endocrine assessments in patients with osteoporosis, obesity, and diabetes.
Management
- Incorporate vibratory therapy as a complementary strategy in managing osteoporosis.
Monitoring & Follow-up
- Monitor bone density and metabolic parameters in patients undergoing VT.
Risks
- Passive vibratory stimulation alone may not provide optimal therapeutic effects.
Patient & Prescribing Data
Patients with osteoporosis, obesity, and diabetes, particularly those with limited exercise tolerance.
VT may offer metabolic and functional benefits when combined with structured physical exercise.
Clinical Best Practices
- Utilize VT in conjunction with pharmacological treatments for osteoporosis.
- Encourage active muscle contractions during VT for enhanced outcomes.
- Implement VT in multidisciplinary programs for weight reduction and metabolic health.
Related Resources & Content
